ScreenPoint Medical’s Transpara AI decision support system can help radiologists to identify potential breast cancers earlier and faster, according to a new study published in Radiology. The ground breaking evidence-based software is already in clinical use in over 30 countries including the USA, France, Germany and Spain. The incidence of breast cancer is increasing worldwide…
QUÈ TREURE D'AQUEST ARTICLE:
- The ground breaking evidence-based software is already in clinical use in over 30 countries including the USA, France, Germany and Spain.
- ScreenPoint Medical’s Transpara AI decision support system can help radiologists to identify potential breast cancers earlier and faster, according to a new study published in Radiology.
- La subscripció és GRATUÏTA.